Phase i dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer

R. D. Kim, S. R. Alberts, C. Peña, I. Genvresse, A. Ajavon-Hartmann, C. Xia, A. Kelly, J. E. Grilley-Olson

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Phase i dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences